Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation

Journal of Craniofacial Surgery

Volumn 16, Issue 6, 2005, Pages 1006-1014

  Hu, ZhenMing ^a,b   Peel, Sean A F ^a   Ho, Stephen K C ^a   Sándor, George K B ^a   Clokie, Cameron M L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bone matrix proteins; Bone morphogenetic proteins; mRNA expression; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PARATHYROID HORMONE RECEPTOR; PLATELET DERIVED GROWTH FACTOR A; SIALOPROTEIN; VASCULOTROPIN; DNA; OSTERIX PROTEIN, RAT; PHOSPHOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR A; SIALOGLYCOPROTEIN; SPP1 PROTEIN, RAT; TRANSCRIPTION FACTOR; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; BONE GRAFT; BONE MARROW CELL; BONE MATRIX; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; ENZYME ASSAY; FRACTURE HEALING; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; ANIMAL; BONE DEVELOPMENT; CATTLE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; LEWIS RAT; MALE; METABOLISM;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COLLAGEN TYPE I; DNA; MALE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; PHOSPHOPROTEINS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED LEW; SIALOGLYCOPROTEINS; STROMAL CELLS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646985153     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.scs.0000170449.72040.ee     Document Type: Article

References (37)

1. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor-b gene family members and bone. Endocrine Rev 1994;15:27-39
2. Raddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-252
3. Reddi AH. Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg Am 2001;1:S1-S6
4. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899
5. Kim CS, Choi SH, Choi BK, Chai JK, Park JB, Kim CK, Cho KS. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132
6. Yamaguchi A, Ishizuya T, Kintou N, et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996;220:366-371
7. Ripamonti U, Ma SS, van de Heever B, Reddi AH. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induced rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg 1992;90:382-393
8. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA. Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int 1998;62:74-82
9. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 1979;76:1828-1832
10. Wu ZY, Hu XB. Separation and purification of porcine bone morphogenetic protein. Clin Orthop 1988;230:229-236
11. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001;19:180-192
12. Galmiche MC, Koteliansky VE, Briere J, Herve P, Charbord P. Stromal cells from long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993;82:66-76
13. Yao KL, Todescan R, Jr, Sodek J. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 1994;9:231-240
14. Peel SA, Hu ZM, Clokie CM. In search of the ideal bone morphogenetic protein delivery system: In vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofacial Surgery 2003;14:284-291
15. Derkx P, Nigg AL, Bosman FT, BirkenhAger-Frenkel DH, Houtsmuller AB. Immunolocalization and quantification of noncollagenous bone matrix proteins in methylmethacrylate-embedded adult human bone in combination with histomorphometry. Bone 1998;22:367-373
16. Narisawa S, Frohlander N, Millan JL. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 1997;208:432-446
17. Noda M, Yoon K, Rodan GA, Koppel DE. High lateral mobility of endogenous and transfected alkaline phosphatase: A phosphatidylinositol-anchored membrane protein. J Cell Biol 1987;105:1671-1677
18. Boskey AL. Noncollagenous matrix proteins and their role in mineralization. Bone Miner 1989;6:111-123
19. Gronthos S, Chen S, Wang CY, Robey P, Sha, S. Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of cbfa1, osterix, and osteocalcin. J Bone Miner Res 2003;18:716-722
20. Domon S, Shimokawa H, Yamaguchi S, Kunimichi S. Temporal and spatial mRNA expression of bone sialoprotein and type I collagen during rodent tooth movement. Eur J Orthod 2001;23:339-348
21. Lecanda F, Avioli LV, Cheng SL. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997;67:386-396
22. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Beheringer RR, de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29
23. Bellows CG, Reimers SM, Heersche JN. Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1, 25 dihydroxyvitamin D3. Cell Tissue Res 1999;297:249-259
24. Oliveira PT, Zalzal SF, Irie K, Nanci A. Early expression of bone matrix proteins in osteogenic cell cultures. J Histochem Cytochem 2003;51:633-641
25. Ibaraki K, Termine JD, Whitson SW, Young MF. Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 1992;7:743-754
26. Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J. Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1 osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 1991;274:513-520
27. Zhou H, Choong P, McCarthy R, Chou ST, Martin TJ, Ng KW. In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 1994;9:1489-1499
28. Mizuno M, Imai T, Fujisawa R, Tani H, Kuboki Y. Bone sialoprotein (BSP) is a crucial factor for the expression of osteoblastic phenotypes of bone marrow cells cultured on type I collagen matrix. Calcif Tissue Int 2000;66:388-396
29. Bautz F, Rafii S, Kanz L, Mohle R. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 2000;28:700-706
30. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143:1545-1553
31. Basciani S, Mariani S, Arizzi M, et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab 2002;87:2310-2319
32. Corti S, Salani S, Del Bo R, et al. Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res 2001;268:36-44
33. Midy V, Ploüet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994;199:380-386
34. Yeh LC, Lee JC. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 1999;153:113-124
35. Amizuka N, Karaplis AC, Henderson HE, et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 1996;175:166-176
36. Terkeltaub RA, Johnson K, Rohnow D, Goomer R, Burton D, Deftos LJ. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells). J Bone Miner Res 1998;13:931-941
37. McCarthy TL, Centrella M, Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1989;124:1247-125